Neutralizing antibody response elicited by SARS-CoV-2 receptor-binding domain

Neutralizing antibody response elicited by SARS-CoV-2 receptor-binding domain

A safe and effective vaccine candidate is urgently needed for the ongoing COVID-19 pandemic, caused by SARS-CoV-2. Here we report that recombinant SARS-CoV-2 RBD protein immunization in mice is able to elicit a strong antibody response and potent neutralizing capability as measured using live or pse...

Full description

Bibliographic Details
Main Authors: Ping-Han Huang, Hsiao-Han Tsai, Bo-Hung Liao, Yi-Ling Lin, Jia-Tsrong Jan, Mi-Hua Tao, Yu-Chi Chou, Che-Ming Jack Hu, Hui-Wen Chen
Format: Article
Language:English
Published: Taylor & Francis Group 2021-03-01
Series:Human Vaccines & Immunotherapeutics
Subjects:
sars-cov-2
receptor-binding domain
vaccine
neutralizing antibodies
Online Access:http://dx.doi.org/10.1080/21645515.2020.1814098

Internet

http://dx.doi.org/10.1080/21645515.2020.1814098

Similar Items